Plain-English translation of NCT07118358 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new pacemaker system called LivIQ that is designed differently from traditional pacemakers — it's a tiny device that gets placed directly in your heart without any wires or leads. The trial will follow 325 patients across hospitals in the U.S., Europe, and Asia Pacific to make sure this new treatment works safely and effectively for people whose hearts don't beat at a healthy rhythm.
Traditional pacemakers require wires that run from a device under the collarbone down into the heart, which can sometimes cause complications over time. This trial exists to see if a smaller, leadless device can provide the same benefits while avoiding some of the problems associated with wires.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will have the LivIQ pacemaker implanted in a procedure, then visit the study hospital several times over the first year (at discharge, 1 month, 3 months, 6 months, and 12 months) so doctors can check how the device is working. After U.S. approval of the device, there will be an additional remote visit at 24 months to confirm your health status. The study team will monitor you closely to make sure the device is functioning properly and that you are doing well.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States
Australia